Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease.
Ontology highlight
ABSTRACT: CLN1 disease is a fatal inherited neurodegenerative lysosomal storage disease of early childhood, caused by mutations in the CLN1 gene, which encodes the enzyme Palmitoyl protein thioesterase-1 (PPT-1). We recently found significant spinal pathology in Ppt1-deficient (Ppt1-/-) mice and human CLN1 disease that contributes to clinical outcome and precedes the onset of brain pathology. Here, we quantified this spinal pathology at 3 and 7 months of age revealing significant and progressive glial activation and vulnerability of spinal interneurons. Tandem mass tagged proteomic analysis of the spinal cord of Ppt1-/-and control mice at these timepoints revealed a significant neuroimmune response and changes in mitochondrial function, cell-signalling pathways and developmenta
SUBMITTER: Nelvagal HR
PROVIDER: S-EPMC7495486 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA